At the upcoming 13th edition of the Probiotics, Prebiotics, and New Food Congress in Rome, Professor Emma Allen-Vercoe, PhD from the University of Guelph (Canada), will present groundbreaking research on…
Targeting E. lenta or boosting neutrophil function may lead to new treatment strategies for bronchiectasis and related lung diseases.
Nutrient competition is the main mechanism of C. difficile inhibition, hinting at the potential for targeted therapies with probiotics instead of traditional FMT.
Introducing more natural microbes could improve astronauts’ health.
Researchers have developed new tools to better understand the role of Bifidobacterium breve, revealing its competitive growth strategies and potential for supporting the immune system.
Is the microbiome just a trend or the future of health? Welcome to the first article of the Bold Column.
Delayed microbiota maturation in infants with cystic fibrosis could contribute to disease complications, highlighting potential therapeutic targets.
Understanding the complex interactions between exercise, diet and gut health can help to develop approaches to influence the gut microbiota, boost immunity and prevent or manage gastrointestinal diseases.
Professor Jacques Ravel, from University of Maryland School of Medicine and LUCA Biologics, discusses his latest research and therapeutic innovations in the field of vaginal microbiome modulation.
Phages could be used as a drug delivery system for conditions such as inflammation and obesity.
